
The von Willebrand factor antigen test measures how much von Willebrand factor protein is present in your blood. Von Willebrand factor, often shortened to vWF or VWF, helps platelets stick to an injured blood vessel and helps carry factor VIII, another important clotting protein. A low vWF antigen result points toward a reduced amount of this protein and raises concern for von Willebrand disease, acquired von Willebrand syndrome, or another cause of bleeding tendency. A high result often reflects inflammation, stress, pregnancy, estrogen exposure, aging, liver disease, or blood vessel activation rather than a bleeding disorder.
Most laboratories report vWF antigen as a percentage or as IU/dL. A common adult reference range is about 50–200 IU/dL, and some laboratories use 55–200%. The number matters, but it is not enough by itself. Symptoms, bleeding history, blood type, vWF activity, factor VIII activity, and repeat testing often determine what the result truly means.
- A typical vWF antigen normal range is about 50–200 IU/dL or 50–200%, but the exact range depends on the laboratory.
- A low vWF antigen result means the blood has a reduced amount of von Willebrand factor protein, which increases suspicion for von Willebrand disease when bleeding symptoms fit.
- A high vWF antigen result usually reflects inflammation, stress, pregnancy, estrogen therapy, aging, liver disease, or blood vessel activation.
- Blood type O often has lower baseline vWF levels, so mildly low or low-normal results need careful interpretation.
- The vWF antigen test measures quantity, not function; vWF activity and factor VIII tests usually complete the first-line evaluation.
- Repeat testing is common because vWF changes with illness, exercise, stress, hormones, pregnancy, and sample handling.
Table of Contents
- What the vWF Antigen Test Measures
- Normal Range and Reference Values
- What Low vWF Antigen Means
- What High vWF Antigen Means
- vWF Antigen vs vWF Activity and Factor VIII
- Test Preparation, Sample Handling, and Accuracy
- How Doctors Interpret Results in Real Life
- Next Steps After an Abnormal Result
What the vWF Antigen Test Measures
The vWF antigen test measures the amount of von Willebrand factor protein in plasma, the liquid part of blood. It answers a quantity question: “How much vWF protein is present?” It does not fully answer a function question: “Does that vWF work properly?”
Von Willebrand factor supports clotting in two main ways. First, it helps platelets attach to injured blood vessel walls, especially in areas where blood moves quickly. Platelets are small blood cells that form the first plug at a cut or damaged vessel. Second, vWF carries and protects factor VIII, a clotting protein needed for stable fibrin clot formation. Without enough vWF, factor VIII often falls because it breaks down faster in the bloodstream.
This is why low vWF often causes mucocutaneous bleeding, meaning bleeding from surfaces such as the nose, gums, skin, uterus, and digestive tract. Common examples include frequent nosebleeds, easy bruising, heavy menstrual bleeding, prolonged bleeding after dental work, and extra bleeding after surgery or childbirth.
The vWF antigen test is often ordered when someone has:
- A personal history of unusual bleeding
- A family history of von Willebrand disease
- Heavy menstrual bleeding from a young age
- Recurrent nosebleeds or gum bleeding
- Easy bruising without clear injury
- Prolonged bleeding after dental extraction, surgery, miscarriage, or delivery
- Abnormal screening clotting tests that need follow-up
- A known diagnosis of von Willebrand disease needing monitoring before procedures
The result is most useful when it is part of a broader bleeding evaluation. A normal or near-normal antigen result does not always rule out von Willebrand disease because some people have normal amounts of vWF that does not function properly. That is why doctors often pair this test with vWF activity testing and factor VIII activity.
The test also helps distinguish von Willebrand disease from hemophilia A. Both conditions involve factor VIII, but the pattern differs. In hemophilia A, factor VIII is low because the body has a factor VIII problem. In von Willebrand disease, factor VIII can be low because vWF is too low or cannot bind factor VIII properly.
Normal Range and Reference Values
A common vWF antigen normal range is about 50–200 IU/dL, which is often reported as 50–200%. Some laboratories use a range such as 55–200%. A result near 100 IU/dL or 100% is close to the average level used by many assays.
Laboratories set their own reference intervals based on the test method, patient population, calibration system, and reporting units. Always compare your result with the reference range printed on your own report.
| vWF antigen result | Common wording | Usual meaning |
|---|---|---|
| About 50–200 IU/dL or 50–200% | Typical reference range | Often considered within the expected adult range, though symptoms and activity results still matter. |
| 40–50 IU/dL or 40–50% | Borderline low or low-normal in some settings | Often needs repeat testing and clinical review, especially with bleeding symptoms or family history. |
| 30–50 IU/dL or 30–50% | Low vWF range | Raises concern for low vWF or type 1 von Willebrand disease when abnormal bleeding is present. |
| Below 30 IU/dL or below 30% | Clearly low | Strongly supports a quantitative vWF deficiency, especially when confirmed on repeat testing. |
| Above the upper reference limit, often above 200% | High vWF antigen | Usually reflects inflammation, stress, pregnancy, estrogen exposure, aging, liver disease, or vascular activation. |
The units look different, but the practical meaning often matches. A result of 50 IU/dL is roughly the same as 50% in many reports. Some guidelines and research papers use IU/mL instead. In that format, 0.50 IU/mL equals 50 IU/dL, and 0.30 IU/mL equals 30 IU/dL.
Why “normal” is not one fixed number
vWF levels vary more than many blood markers. Your baseline level is influenced by genetics, age, blood type, hormones, inflammation, and physical stress. Blood type O is especially important. People with blood type O often have lower vWF levels than people with non-O blood types. This means a result around 45–55% needs more context than the word “low” or “normal” on a lab report can provide.
Age also matters. vWF levels tend to rise over time. A person with mild type 1 von Willebrand disease can have levels that move into the lab’s normal range later in life, even though their earlier bleeding history remains real. Pregnancy and estrogen exposure also raise vWF, which can temporarily hide mild deficiency.
Normal range is not the same as optimal range
There is no widely used “optimal” vWF antigen target for healthy adults. The goal is not to push vWF toward the middle or top of the reference range. The goal is to understand whether the amount and function of vWF are enough for safe clotting during daily life, menstruation, dental work, surgery, childbirth, and injury.
A person with 58% and no bleeding history often needs no treatment. Another person with 58%, heavy menstrual bleeding, frequent nosebleeds, and a family history of von Willebrand disease needs deeper evaluation. The same number has different meaning in different people.
What Low vWF Antigen Means
A low vWF antigen result means the blood contains less von Willebrand factor protein than expected. The most common concern is a quantitative form of von Willebrand disease, especially type 1 von Willebrand disease. In type 1, the body makes reduced amounts of vWF, but the vWF that is present usually works normally.
Low vWF antigen is most meaningful when it matches a bleeding pattern. Doctors look for symptoms such as heavy periods, nosebleeds lasting more than 10 minutes, easy bruising, prolonged gum bleeding, bleeding after tooth extraction, postpartum bleeding, or bleeding after surgery. The test result and bleeding history need to fit together.
Common causes and associations of low vWF antigen include:
- Type 1 von Willebrand disease: partial reduction in vWF amount
- Type 3 von Willebrand disease: severe or near-complete lack of vWF
- Acquired von Willebrand syndrome: reduced vWF due to another condition rather than inherited disease
- Blood type O: lower baseline vWF levels, sometimes near the lower edge of the reference range
- Hypothyroidism: an underactive thyroid sometimes contributes to acquired low vWF
- Certain heart valve or blood flow disorders: abnormal shear stress can reduce large vWF multimers
- Some immune, lymphoid, or plasma cell disorders: antibodies or abnormal proteins can interfere with vWF
A low vWF antigen result often leads to repeat testing because vWF changes over time. Testing during a calm, well state often gives a better baseline than testing during infection, intense exercise, pregnancy, or acute stress. If the repeat result remains low and the bleeding history fits, a clinician often orders a full von Willebrand disease panel.
Low vWF versus von Willebrand disease
Low vWF and von Willebrand disease overlap, but they are not always identical labels. Some people have vWF levels in the 30–50 IU/dL range with mild or inconsistent bleeding. Clinicians often describe this as “low vWF,” especially when the result does not fully meet diagnostic criteria for von Willebrand disease.
A result below 30 IU/dL is more strongly linked to inherited von Willebrand disease, particularly when found more than once. A result below 50 IU/dL with abnormal bleeding also supports the diagnosis in many clinical settings. Still, the final diagnosis comes from the full pattern: symptoms, family history, antigen, activity, factor VIII, activity-to-antigen ratio, and sometimes multimer or genetic testing.
For a focused explanation of causes and bleeding risk, the related guide on low vWF antigen results gives more detail.
Bleeding symptoms that make a low result more important
A borderline or mildly low result deserves closer attention when the person has:
- Heavy menstrual bleeding since the first years of menstruation
- Iron deficiency from menstrual blood loss
- Nosebleeds that are frequent, prolonged, or hard to stop
- Easy bruising with large bruises or bruises in unusual places
- Bleeding after dental extraction
- Bleeding after tonsil surgery, childbirth, miscarriage, or major surgery
- A first-degree relative with von Willebrand disease
- Low factor VIII without another clear cause
Low vWF does not always cause day-to-day bleeding. Some people first discover the problem only after surgery, injury, childbirth, or a dental procedure. This is why pre-procedure planning matters when a person has a known low result.
What High vWF Antigen Means
A high vWF antigen result means the blood contains more von Willebrand factor protein than the lab’s reference range expects. High vWF antigen is not the usual pattern for von Willebrand disease. It more often reflects the body’s response to inflammation, stress, hormones, aging, liver disease, or blood vessel injury.
vWF is an acute-phase reactant. That means levels rise during inflammatory or stressful states, much like some other inflammation-related blood markers. The body releases vWF from endothelial cells, which line blood vessels. When those cells are activated, vWF often rises.
Common reasons for high vWF antigen include:
- Acute infection or recent illness
- Chronic inflammation
- Physical stress, trauma, or recent surgery
- Intense exercise before the blood draw
- Pregnancy
- Estrogen-containing medications or hormone therapy
- Aging
- Liver disease
- Vasculitis or blood vessel inflammation
- Diabetes, kidney disease, or cardiovascular disease in some patients
- Thrombotic microangiopathy patterns such as thrombotic thrombocytopenic purpura or hemolytic uremic syndrome
A high result does not automatically mean a dangerous clot is present. It is a signal, not a diagnosis. Doctors interpret it with symptoms, other clotting markers, inflammatory markers, liver tests, kidney tests, platelet count, and the reason the test was ordered.
High vWF antigen also complicates von Willebrand disease testing. A person with mild inherited low vWF might test normal or high during pregnancy, infection, inflammation, or major stress. If the clinical suspicion is strong, repeat testing at baseline is often more useful than relying on one elevated result.
For deeper detail on causes and risk patterns, see the related article on high vWF antigen test results.
Does high vWF antigen mean higher clot risk?
High vWF antigen is linked with blood vessel activation and has been associated with higher clotting and cardiovascular risk in some medical settings. However, the test is not used alone to predict clots in an otherwise stable person. A high value becomes more meaningful when it appears with other risk factors, such as active inflammation, cancer, severe infection, major surgery, immobility, pregnancy complications, or known vascular disease.
A high vWF antigen result should prompt a practical question: “What is driving the elevation?” The answer often comes from the surrounding clinical picture rather than from the vWF result alone.
vWF Antigen vs vWF Activity and Factor VIII
The vWF antigen test measures amount. The vWF activity test measures function. Factor VIII activity measures a clotting protein that vWF carries and protects. These tests work best together because von Willebrand disease includes both quantity and quality problems.
| Test | What it measures | Why it matters |
|---|---|---|
| vWF antigen | Amount of vWF protein in plasma | Finds reduced quantity, especially in type 1 and type 3 von Willebrand disease. |
| vWF activity | How well vWF supports platelet binding | Finds functional problems, especially type 2 variants. |
| Factor VIII activity | Activity level of clotting factor VIII | Helps separate von Willebrand disease patterns from hemophilia A and type 2N VWD. |
| vWF activity-to-antigen ratio | Function compared with amount | Helps identify type 2 von Willebrand disease when activity is disproportionately low. |
| vWF multimer analysis | Size pattern of vWF molecules | Helps subtype type 2 disease and evaluate loss of high-molecular-weight multimers. |
In type 1 von Willebrand disease, vWF antigen and vWF activity usually fall together. In type 2 von Willebrand disease, the antigen level can be normal or only mildly low, but activity is lower than expected for the amount of protein present. In type 3 disease, vWF antigen is extremely low or undetectable, and factor VIII is often very low.
The activity-to-antigen ratio is a key clue. When vWF activity is much lower than vWF antigen, the body has vWF protein, but the protein is not working properly. This pattern raises concern for type 2 variants, including type 2A, 2B, or 2M. Type 2N is different because the main problem is poor binding between vWF and factor VIII, so factor VIII is disproportionately low.
Factor VIII is important because low factor VIII can prolong the activated partial thromboplastin time, or aPTT. A normal aPTT does not rule out von Willebrand disease, especially mild disease. Still, an abnormal aPTT can guide further testing. Readers comparing clotting times with vWF results can review aPTT reference values for more context.
A broader coagulation panel checks related clotting markers, but routine screening tests often miss mild von Willebrand disease. Someone can have normal PT, INR, platelet count, and even a normal aPTT while still having clinically meaningful low vWF or abnormal vWF function.
Test Preparation, Sample Handling, and Accuracy
Most people do not need to fast before a vWF antigen blood test. The sample is usually drawn into a light-blue-top tube containing sodium citrate, an anticoagulant used for clotting tests. The laboratory processes the sample into platelet-poor plasma because platelet contamination can interfere with accurate measurement.
Good sample handling matters. Coagulation testing is sensitive to collection and processing details. Underfilled tubes, clotted samples, delayed processing, lipemia, and poor freezing or transport conditions can distort results. If a result does not fit the person’s symptoms, clinicians often repeat the test rather than making a major decision from one sample.
Several everyday factors raise vWF antigen temporarily:
- Fever or infection
- Recent injury or surgery
- Emotional stress or pain
- Strenuous exercise
- Pregnancy
- Estrogen-containing birth control or hormone therapy
- Active inflammation
- Poorly controlled chronic disease
- Recent bleeding or anemia-related stress
Some factors lower or complicate interpretation:
- Blood type O
- Mild inherited vWF deficiency
- Hypothyroidism
- Acquired von Willebrand syndrome
- Certain blood, immune, or heart valve conditions
- Sample collection or processing problems
Timing matters for menstrual and pregnancy-related evaluation. During pregnancy, vWF and factor VIII often rise, especially later in pregnancy. Testing during pregnancy helps plan delivery in someone with known von Willebrand disease, but it does not always show the person’s nonpregnant baseline. After delivery, levels fall again, and postpartum bleeding risk needs separate planning.
Testing during acute illness also creates confusion. A person with mild low vWF may appear normal during infection or inflammation. If the bleeding history strongly suggests von Willebrand disease, a normal result during illness should not close the evaluation.
Medicines and supplements
The vWF antigen test itself does not require stopping most medicines. However, medicines matter when doctors evaluate bleeding. Aspirin, nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen, antiplatelet drugs, anticoagulants, some antidepressants, fish oil at high doses, and some herbal products can worsen bleeding or affect platelet function.
Do not stop prescribed anticoagulants, antiplatelet medicines, hormones, or other long-term medicines unless the ordering clinician tells you to. The safer approach is to give the clinician a complete list of medicines and supplements before interpreting results.
How Doctors Interpret Results in Real Life
Doctors do not interpret vWF antigen as an isolated number. They combine the result with the reason for testing, personal bleeding history, family history, medication list, blood type, other clotting tests, and the timing of the blood draw.
A practical interpretation starts with three questions.
First, is there a real bleeding pattern? Heavy menstrual bleeding, recurrent nosebleeds, dental bleeding, postpartum hemorrhage, and surgical bleeding carry more weight than occasional small bruises. A formal bleeding assessment tool sometimes helps organize this history.
Second, does the lab pattern match a known von Willebrand pattern? Low antigen and low activity together suggest a quantity problem. Low activity with normal or mildly low antigen suggests a function problem. Low factor VIII with relatively preserved vWF antigen suggests a factor VIII-related pattern, hemophilia A, or type 2N von Willebrand disease.
Third, was the person at baseline when tested? Illness, stress, pregnancy, estrogen exposure, inflammation, or recent exercise can raise vWF. A single normal result during one of those states does not always reflect the person’s usual level.
| Pattern | Possible interpretation | Common follow-up |
|---|---|---|
| Low vWF antigen and low vWF activity | Quantitative vWF deficiency, often type 1 VWD when mild or type 3 when severe | Repeat panel, factor VIII, bleeding history review, hematology referral when significant |
| Normal vWF antigen but low vWF activity | Possible qualitative vWF problem, especially type 2 VWD | Activity-to-antigen ratio, multimer analysis, specialized subtype testing |
| Low factor VIII with low vWF antigen | vWF deficiency lowering factor VIII stability | Full VWD panel and procedure planning if bleeding risk is present |
| Low factor VIII with normal vWF antigen | Hemophilia A or type 2N VWD pattern | Factor VIII workup and specialized vWF-factor VIII binding evaluation when needed |
| High vWF antigen | Inflammation, stress, pregnancy, estrogen effect, aging, liver disease, or vascular activation | Look for the cause, repeat at baseline if evaluating possible mild VWD |
A normal platelet count does not rule out von Willebrand disease. Platelets can be normal in number but still fail to attach well if vWF is low or dysfunctional. If the platelet count itself is abnormal, interpretation changes. A related platelet count reference guide helps separate platelet number problems from vWF-related platelet adhesion problems.
Family history also matters, but it is not always obvious. Mild von Willebrand disease sometimes goes undiagnosed for generations. Relatives may report “heavy periods,” “bad nosebleeds,” “bleeding after dental work,” or “needed a transfusion after childbirth” without ever receiving a formal diagnosis.
Next Steps After an Abnormal Result
The right next step depends on the result, symptoms, and upcoming medical needs. A mildly low result in a person with no bleeding history often leads to repeat testing and observation. A low result in someone with significant bleeding usually deserves a complete von Willebrand workup. A high result often leads to a search for inflammation, pregnancy, liver disease, vascular disease, or another active medical trigger.
Common follow-up steps include:
- Repeat the vWF panel at baseline. Testing again when you are well, not pregnant, not recovering from surgery, and not acutely inflamed often gives a clearer baseline.
- Add vWF activity and factor VIII activity. These tests show whether the protein works and whether factor VIII is affected.
- Review blood type. Blood type O lowers baseline vWF in many people and helps explain borderline results.
- Check iron status if bleeding is heavy. Heavy menstrual bleeding or chronic nosebleeds often cause iron deficiency even before anemia appears.
- Review medicines that worsen bleeding. Aspirin, NSAIDs, anticoagulants, and antiplatelet drugs need special attention before procedures.
- Refer to hematology when results and symptoms are significant. A hematologist can order subtype testing and prepare a treatment plan.
Treatment decisions are not based on vWF antigen alone. Options vary by diagnosis and situation. Some people respond to desmopressin, a medicine that releases stored vWF from blood vessel lining cells. Others need vWF-containing concentrates, tranexamic acid, hormonal therapy for heavy menstrual bleeding, iron replacement, or procedure-specific plans. A desmopressin trial is often done under medical supervision when future surgery or childbirth planning requires knowing whether the medication works.
Urgent care is appropriate for bleeding that is heavy, persistent, or associated with weakness, fainting, chest pain, shortness of breath, black stools, vomiting blood, severe headache after trauma, or soaking menstrual products very quickly. People with known or suspected von Willebrand disease should tell surgeons, dentists, obstetric teams, and emergency clinicians before procedures whenever possible.
For planned surgery, dental extraction, endoscopy with biopsy, childbirth, or invasive procedures, the safest approach is early planning. Clinicians often check vWF antigen, vWF activity, factor VIII, CBC, ferritin, and other clotting tests ahead of time. The plan might include medication before the procedure, antifibrinolytic treatment afterward, and monitoring for delayed bleeding.
Questions to ask about your result
Useful questions include:
- What was my vWF antigen result in IU/dL or percent?
- Was my vWF activity also low?
- What was my factor VIII activity?
- Do my results fit type 1, type 2, type 3, low vWF, or acquired von Willebrand syndrome?
- Should I repeat testing when I am well and not under acute stress?
- Does my blood type affect interpretation?
- Do I need a hematology referral before surgery, dental work, pregnancy, or delivery?
- Should I avoid aspirin or NSAIDs because of bleeding risk?
- Do I need iron testing because of heavy menstrual bleeding or frequent blood loss?
The vWF antigen test gives one important piece of the clotting picture. The most useful interpretation comes from matching the number to the person: their bleeding story, family history, other test results, and real-life risk during procedures or childbirth.
References
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease 2021 (Guideline)
- Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors’ Organisation and the British Society for Haematology 2024 (Guideline)
- Low von Willebrand factor—unraveling an enigma wrapped in a conundrum 2024 (Review)
- Clinical and laboratory diagnosis of von Willebrand disease 2026 (Review)
- Von Willebrand disease diagnosis: from complexity to simplicity 2025 (Review)
- Test ID VWAG von Willebrand Factor Antigen, Plasma 2026 (Laboratory Reference)
Disclaimer
This article is educational and does not replace care from a qualified clinician. vWF antigen results need interpretation with your symptoms, bleeding history, medications, other clotting tests, and the reference range from the laboratory that performed the test. Seek urgent medical care for heavy, persistent, unexplained, or dangerous bleeding.





